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Abstract
Objective: To assess correlates of long- acting reversible contraceptive (LARC) use, and 
explore patterns of LARC use among female sex workers (FSWs) in Kenya.
Methods: Baseline cross- sectional data were collected between September 2016 and 
May 2017 in a cluster- randomized controlled trial in Mombasa. Eligibility criteria included 
current sex work, age 16–34 years, not pregnant, and not planning pregnancy. Peer 
educators recruited FSWs from randomly selected sex- work venues. Multiple logistic 
regression identified correlates of LARC use. Prevalence estimates were weighted to 
adjust for variation in FSW numbers recruited across venues.
Results: Among 879 participants, the prevalence of contraceptive use was 22.6% for 
implants and 1.6% for intra- uterine devices (IUDs). LARC use was independently asso-
ciated with previous pregnancy (adjusted odds ratio for one pregnancy, 11.4; 95% 
confidence interval, 4.25–30.8), positive attitude to and better knowledge of fam-
ily planning, younger age, and lower education. High rates of adverse effects were 
reported for all methods.
Conclusion: The findings suggest that implant use has increased among FSWs in Kenya. 
Unintended pregnancy risks remain high and IUD use is negligible. Although LARC rates 
are encouraging, further intervention is required to improve both uptake (particularly of 
IUDs) and greater access to family planning services.
K E Y W O R D S
Cluster-randomized design; Complex sampling; Contraceptive implant; Intra-uterine device; 
Kenya; Long-acting reversible contraception; Sex work
1  | INTRODUCTION
Female sex workers (FSWs) in many countries have high rates of 
unintended pregnancy,1 and experience many barriers to using 
highly effective contraception. They also have difficulties negotiat-
ing condom use with clients and non- paying partners, often facing 
violence or financial incentives not to use condoms.2 Therefore, 
use of condoms alongside a highly effective method is critical for 
 pregnancy prevention.
Long- acting reversible contraceptives (LARCs) including intra- 
uterine devices (IUDs) and subdermal implants, are not user- or coital- 
dependent, and accord women greater control in the face of resistant 
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male partners.1 LARCs are considered safe for nulliparous women and 
women with multiple sexual partners, provided that those with a very 
high risk of sexually transmitted infections (STIs) receive STI screening 
or treatment at the time of IUD insertion.3–5
The use of LARCs among FSWs is low in many countries,6 partic-
ularly in sub- Saharan Africa, where prevalence is reported as less than 
5% in most studies.1,7 Use of IUDs among FSWs varies considerably 
between regions, with higher levels in parts of Latin America and Asia.8,9
Access to family planning services has increased in parts of Africa 
in recent decades.10 In Kenya, LARCs are offered at low or no cost in 
many public health facilities, and are used by approximately 22% of 
married women.11 Uptake by FSWs, however, is unknown. Peer- based 
HIV- prevention programs for FSWs are common in HIV- endemic 
countries, but they seldom offer family planning or other sexual or 
reproductive health services.12,13 Misconceptions and limited knowl-
edge about contraception have further limited access.1
The WHISPER or SHOUT study evaluated the impact of a mobile 
phone intervention on knowledge and attitudes to contraception (with 
a focus on LARCs) and on unintended pregnancy rates in a population 
of FSWs.14 Using baseline data from that trial, the aim of the present 
study was to assess the prevalence and correlates of LARC use, and 
explore patterns of use among FSWs in Mombasa, Kenya.
2  | MATERIAL AND METHODS
The present study analyzed data collected in the WHISPER or 
SHOUT trial 14 on contraceptive use among FSWs in Kenya between 
September 1, 2016, and May 31, 2017. The study was approved by the 
Kenyatta National Hospital, University of Nairobi Ethics and Research 
Committee, Kenya, and the Monash University Human Research 
Ethics Committee, Australia, and was registered with the Australian 
New Zealand Clinical Trial Registry (ACTRN12616000852459). All 
participants provided written informed consent.
The WHISPER or SHOUT study recruited women aged 
16–34 years who self- reported sex work in the past 6 months, had 
a negative urine pregnancy test, and were not planning a pregnancy 
for the next 12 months. Peer educators recruited the women from 
sex work venues such as bars and hotels by using two- stage cluster- 
random sampling. First, 102 sex work venues (clusters) were randomly 
selected from a sampling frame of mapped venues.15 The probability 
of a venue being selected was proportionate to the estimated number 
of FSWs at that venue. Next, peer educators consecutively recruited 
FSWs from the selected venues, aiming for 10 women from each. 
Additional venues were approached until at least 860 women were 
recruited (the target sample size).
After providing written informed consent, participants completed 
a clinical assessment, point- of- care testing for HIV, and a structured 
interviewer- administered questionnaire. Data were collected on elec-
tronic tablets using REDCap electronic data capture tools hosted at 
the Burnet Institute (Vanderbilt University, Nashville, TN, USA).16
The outcome of interest, LARC use, was defined as self- reported 
current use of either contraceptive implants or IUDs. Highly effective 
contraception methods were defined as implant, IUD, injection, oral 
contraceptive pill, and permanent contraception methods (those with 
at least 90% typical use efficacy17). Full details of the study mea-
sures and variable categories are provided in Supplementary File S1. 
Knowledge about family planning was classified as high if participants 
answered at least five of six true- or- false statements correctly. They 
were considered to have a positive attitude to family planning if they 
agreed with at least three of four attitude statements. Self- efficacy 
and stigma were both measured on a 10- item scale,18,19 each rated 
between one and four, with four representing greater self- efficacy or 
stigma. Two additional items measured contraception- specific self- 
efficacy, defined as high if participants agreed with both statements.
All analyses were undertaken in Stata version 13 (StataCorp, 
College Station, TX, USA). Correlates of LARC use were identified by 
using multiple logistic regression, with the level of statistical signifi-
cance set at 0.05. Covariates were included in the model on the basis 
of empirical evidence from previous studies or an a priori theoretical 
basis for this relationship. Exploratory analyses examined the rea-
sons for starting and ceasing use of implants and IUDs. The propor-
tion of women who had experienced adverse effects was calculated, 
and bivariable logistic regression analyses were used to explore the 
association between cessation of implant use and experience of 
adverse effects.
Inverse probability sample weights were derived for each partici-
pant to account for variation in the number of FSWs recruited across 
sex- work venues. Given the non- independence of observations owing 
to sampling FSWs by venue, cluster sandwich variance estimation was 
used to produce corrected standard errors in logistic regression and 
univariate descriptive analyses.
3  | RESULTS
Among 1728 women invited to participate in the study, 1432 (82.8%) 
expressed an interest in participating; of these, 120 (8.4%) did not 
attend screening and 430 (30.0%) were deemed ineligible. The main 
reasons for ineligibility were age (n=119, 27.7%) and not owning a 
mobile phone (n=105, 24.4%) (Fig. 1). In total, 882 eligible women were 
enrolled from 93 venues. Three women were subsequently excluded 
from the analysis because they did not answer the questions on con-
traceptive use, resulting in a sample size of 879 women for the analysis.
The mean age of the participants was 25.4 years, and 494 
(57.1%) women had a boyfriend or husband (non- paying emo-
tional partner) (Table 1). A median of four clients in the past week 
was reported. Three- quarters of participants (n=675, 76.0%) had 
ever been pregnant, and 458 (51.3%) had ever had an unintended 
pregnancy, with 96 (10.8%) having had one in the previous year. 
The prevalence of HIV was 12.1% (95% confidence interval [CI], 
9.7–14.9). One- quarter of women reported currently using a LARC, 
including 204 implant users (22.6%) and 13 IUD users (1.6%) 
(Table 2). Half the women reported using condoms consistently 
with all partners in the past month, with 235 (26.3%) doing so 
alongside another method. Binge drinking was common (n=176, 
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Total sex work venues in study area (n=757)*
Estimated total FSWs=(n=8516)
Randomly selected venues (clusters) (n=102)
Included clusters (n=93)
Individuals invited (n=1728)
(mean 18.6/cluster)
Enrolled (n=882 from 93 clusters)
(mean 9.5/cluster)
Eligible for full screening (n=1155)
Clusters (n=93)
(mean 12.4/cluster)
Attended screening (n=1035)
Clusters (n=93)
(mean 11.1/cluster)
Clusters excluded (n=13)
Closed/not operating (n=5)
Unable to recruit at cluster (n=2)
Couldn’t be located (n=1)
Duplicated (sampling error) (n=1)
Not interested in taking part (n=296)
Ineligible for full screening (n=277)**
Already in RCT or participated in study 
development (n=3)
Not aged 16–34 y (n=109)
No sex work in past 6 mo (n=40)
Not living in the study area (n=26)
No mobile phone (n=88)
Unsupported mobile phone provider (n=11)
Didn’t attend screening (n=120)
Ineligible (153)**
Already in RCT or participated in study 
development (n=7)
Not aged 16-34 y (n=10)
No sex work in past 6 mo (n=4)
Not living in the study area (n=1)
No mobile phone (n=17)
Unsupported mobile phone provider (n=8)
No consent provided (n=3)
Pregnant (n=47)
Planning pregnancy in next year (n=4)
Medical condition preventing enrolment (n=1)
Not SMS literate (n=51)
Excluded from analysis (n=3)
No data on contraceptive use (n=3)
Eligible for analysis (n=879 from 93 clusters)
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19.9%), and 104 (12.0%) women had had sex without a condom 
while drunk in the previous week.
The multivariate logistic regression model included 14 variables 
(Table 3). There was no evidence of effect modification, so interac-
tion terms were not added. In the multivariate analysis, current use 
of LARCs was correlated with gravidity. The odds of LARC use among 
women who reported one previous pregnancy was more than 10- fold 
higher than that of nulliparous women (adjusted odds ratio [aOR], 
11.44; 95% CI, 4.25–30.83), and the association increased with num-
ber of pregnancies. Only six nulliparous women used LARCs (2.8%). 
A high level of family planning knowledge (aOR, 2.52; 95% CI, 1.78–
3.56) and positive attitudes to family planning (aOR, 4.58; 95% CI, 
2.62–8.00) were also associated with LARC use.
In multivariate analysis, LARC users were younger than non- users 
(aOR per year of age, 0.91; 95% CI, 0.86–0.96). Women with at least 
secondary education had a lower odds of LARC use (aOR, 0.42; 95% 
CI, 0.22–0.83) as compared with those who had not completed pri-
mary education. The odds of LARC use was nearly doubled for women 
whose friends used family planning (OR, 1.92; 95% CI, 1.41–2.61) and 
those with high contraceptive self- efficacy (OR, 1.86; 95% CI, 1.19–
2.88) in bivariate analysis. However, both variables were strongly cor-
related with positive attitude to LARC and were not independently 
associated with LARC use after adjustment.
Further analyses explored the experiences of women who had 
ever used LARCs, including reasons for commencement and cessa-
tion, and adverse effects. Three hundred and two (34.2%) women had 
ever used implants. The most commonly reported reason for use was 
their effectiveness at preventing pregnancy (n=173, 56.6%), followed 
by perceived fewer adverse effects (n=49, 16.5%) and longer duration 
of action (n=49, 16.4%) relative to other contraceptives. Overall, 266 
(88.8%) women reported adverse effects, most commonly irregular or 
Characteristic
Value 
(n=879)a 95% CIb
Alcohol use
High- risk drinkingf 176 (19.9) 16.8–23.5
Sex without a condom while drunk 
in past week
104 (12.0) 9.8–14.7
aValues are given as median (interquartile range) or number (percentage) 
unless stated otherwise. Inverse probability- weighted percentages are 
shown (weighted percentages are similar, but not identical to those calcu-
lated from counts).
bStandard errors are corrected by cluster sandwich variance estimation.
c1000 Kenyan shillings is approximately US $10.
dIncludes brothel, casino, strip club, home, and other.
eAmong those with a boyfriend/husband.
fFive or more alcoholic drinks on one occasion at least monthly.
T A B L E  1   (Continued)T A B L E  1   Demographic, reproductive health, sex work, and 
alcohol use characteristics of the study participants.
Characteristic
Value 
(n=879)a 95% CIb
Demographic
Mean age, y 25.4 25.0–25.9
Education (highest level attained)
None or some primary 104 (11.4) 9.4–13.8
Primary or some secondary 463 (53.5) 49.8–57.2
Secondary or some tertiary 312 (35.1) 31.5–38.8
Religion
Protestant 391 (44.1) 40.7–47.6
Catholic 310 (36.1) 32.4–40.0
Muslim 171 (18.9) 15.4–23.0
Other 5 (0.9) 0.3–2.3
Weekly income from sex work, shillingsc
<1000 146 (16.2) 13.2–19.8
1000–2000 215 (24.1) 21.1–27.3
>2000 515 (59.7) 55.0–64.3
Number of living children
0 248 (28.8) 25.0–32.9
1 312 (35.8) 31.8–40.0
≥2 319 (35.4) 31.2–39.9
Current boyfriend/husband 494 (57.1) 52.9–61.1
Reproductive health
Intimate partner violence in past 
12 mo
531 (60.0) 55.3–64.5
Pregnancy history
Ever pregnant 675 (76.0) 72.2–79.4
Ever had an unintended pregnancy 458 (51.3) 47.5–55.0
Unintended pregnancy in past 
12 mo
96 (10.8) 8.9–13.2
Sex and sex work practices
Main venue for meeting clients
Bar with lodging 397 (44.2) 38.0–50.5
Bar without lodging 147 (16.9) 13.5–21.0
Lodging/guesthouse 140 (15.1) 10.9–20.5
Street/beach 86 (11.0) 7.7–15.5
Otherd 109 (12.8) 9.2–17.5
Clients in past week 4 (3–6)
Number of non- paying partners (boyfriends/husbands) in the past 
wke
0 40 (7.4) 5.1–10.7
1 399 (81.7) 77.1–85.5
≥2 54 (10.9) 8.0–14.7
Disclosure of sex work status to 
boyfriend/husbande
138 (28.6) 24.3–33.4
(Continues)
F I G U R E  1   Flow diagram showing recruitment of the study population for the WHISPER or SHOUT trial as per the Consort 2010 statement: 
“extension to cluster randomized trials”.36 Asterisk: total hotspots and number of FSWs per hotspot in the study area, as enumerated by Cheuk 
et al.15 Double asterisk: one reason for ineligibility is reported per participant; criteria were determined in the order shown. Abbreviation: FSW, 
female sex worker.
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heavy bleeding (n=139, 45.6%), lighter or no bleeding (n=123, 42.0%), 
and pelvic pain (n=93, 30.8%). One- third of those who had ever used 
implants were no longer doing so (n=98, 34.1%), mostly because of 
adverse effects (n=81, 83.2%). The adverse effects most strongly 
associated with cessation were heavier bleeding (OR, 3.26; 95% CI, 
1.70–6.28), nausea (OR, 3.73; 95% CI, 2.06–6.74), and weight loss 
(OR, 3.79; 95% CI, 2.22–6.47).
Overall, 40 (4.6%) women had ever used IUDs; the main reasons for 
commencing use were perceived fewer adverse effects (n=20, 51%) and 
effectiveness at preventing pregnancy (n=16, 38%). Three- quarters of 
IUD users reported adverse effects (n=30, 76%), predominantly pelvic 
pain (n=19, 50%), heavier bleeding (n=10, 26%), and irregular bleeding 
(n=8, 22%). Twenty- seven (65%) IUD users had ceased use; 17 of them 
cited adverse effects as the reason.
Similar to LARCs, adverse effects were common with other con-
traceptives, affecting 189 (90.0%) of pill users and 397 (87.4%) of 
injection users. Rates of cessation were also high with these meth-
ods: 66.0% for oral contraceptives and 57.0% for injections. Adverse 
effects and difficulty of use were the main reasons for ceasing these 
methods. Few women reported stopping male (n=11, 2%) or female 
(n=1, 6%) condoms.
Among the current implant users, implants had been obtained 
from government health centers (n=86, 42.1%), government hospi-
tals (n=48, 23.7%), mobile outreach services (n=24, 11.9%), and pri-
vate hospitals or clinics (n=23, 10.9%). Only 10 (5%) women reported 
obtaining them from sex- worker drop- in centers. A similar pattern was 
noted for IUDs. In contrast, injections were largely obtained from pri-
vate hospitals or clinics (n=71, 36.0%), and contraceptive pills (n=31, 
45%) and emergency contraceptives (n=3, 97%) from pharmacies. 
Male condoms were sourced from varied locations including pharma-
cies (n=217; 27.4%), government health centers (n=101, 13.4%) and 
sex- worker drop- in centers (n=86; 11.7%).
4  | DISCUSSION
The present study recruited a large representative sample of FSWs 
from 93 sites in Mombasa, Kenya. Encouragingly, implant use was 
approximately fourfold higher than, and the 1- year period prevalence 
of unintended pregnancy was approximately half of the values esti-
mated in 2007 1 and 2008.7 Although the two earlier studies did not 
use random sampling and included a wider age range, the magnitude 
of the differences suggests that the present findings are due to real 
changes in the FSW population. The present findings also suggest that 
implant use is more prevalent among FSWs (22.6%) than among the 
general population (11%).20 Nevertheless, this population still faces 
considerable risks, owing to multiple paying and non- paying partners, 
low use of dual- method contraception, endemic intimate partner vio-
lence, and high- risk drinking with associated sexual risk- taking.
Improvements in implant coverage were not matched by the rate 
of IUD use (1.6%), which remained negligible and consistent with low 
estimates in the general population (3%).20 Fewer public facilities pro-
vide IUDs as compared with other contraceptives.20 Access is also lim-
ited by providers’ misconceptions about IUDs 21 and interpretation of 
medical eligibility criteria, with many providers continuing to assume 
that higher- risk women are ineligible for IUD insertion.22
In the present study, gravidity was the strongest independent cor-
relate of LARC use, reflecting similar results in non- sex- worker pop-
ulations.23 This may be because women decide to use longer- acting 
methods after completing their family or experiencing unintended 
pregnancy. However, it may also reflect an enduring assumption that 
LARCs are inappropriate for nulliparous women.21
Unexpectedly, younger age and lower education were inde-
pendently associated with LARC use. Younger, less educated women 
may experience greater difficulty in returning to a clinic for short- 
acting methods, making LARCs more convenient.24 An association 
between use of any contraceptive by FSWs and older age has been 
T A B L E  2   Contraceptive use characteristics of the sample 
population.
Contraceptive use No. (%)a 95% CIb
Current contraceptive use
Highly effective method  
(± condoms)
482 (54.6) 49.8–59.3
Other non- barrier method  
(± condoms)
53 (5.8) 4.2–7.9
Condoms only 336 (38.8) 34.2–43.5
None 8 (0.9) 0.4–1.9
Current methods of contraceptionc
Condoms (any)d 845 (96.3) 94.1–97.7
Female condoms 14 (1.6) 0.9–2.6
IUD 13 (1.6) 0.9–2.7
Implant 204 (22.6) 19.2–26.3
Pill 68 (8.3) 6.3–10.9
Injection 199 (22.3) 19.3–25.7
Permanent 1 (0.1) 0.01–0.8
Emergency pill 34 (3.7) 2.6–5.1
Natural method (LAM, cycle 
beads, withdrawal
23 (2.5) 1.6–3.9
Consistent condom use during all sex acts in past month
With clientse 669 (76.4) 72.3–80.1
With boyfriends/husbandf 157 (32.2) 28.1–36.6
With all partners 441 (50.4) 46.2–54.5
Dual method use (consistent 
condom use + another highly 
effective method)
235 (26.3) 22.6–30.5
Abbreviations: IUD, intra- uterine device; LAM, lactational amenorrhea method.
aInverse probability- weighted percentage.
bStandard errors are corrected by cluster sandwich variance estimation.
cCategories are not mutually exclusive.
dThose reporting current use of male or female condoms, or stating use of 
condoms mostly/always in the past month.
eAmong those who had sex with clients in the past month (n=874).
fAmong those who had sex with a boyfriend or husband in the past 
month (n=486).
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noted,1,25 but it may reflect the predominance of condoms and short- 
acting methods in those studies, or the influence of gravidity. Studies 
examining LARC use in non- sex- worker populations have rarely found 
a clear association with age,23,24 and have reported mixed results 
regarding education.23,26
Knowledge and positive attitude to family planning were cor-
relates of LARC use, consistent with findings in other populations.26 
Social norms and contraceptive self- efficacy may lie on the same 
causal pathway as positive attitude, or may measure the same under-
lying construct. Education about LARCs has been found to improve 
attitude and uptake.21 In the present sample, these individual factors 
had greater influence on LARC use than structural factors such as the 
presence of a boyfriend or husband, sex- work- related stigma, and 
violence. This is surprising given the known influence of structural 
determinants on sexual health risks.2,25,27 Structural determinants may 
have a greater influence on use of condoms and other user- dependent 
methods than on LARC use.
Adverse effects were experienced by most women for all highly 
effective contraceptive methods and seemed to be more common 
than reported elsewhere.28,29 The rate of LARC discontinuation was 
high, but the duration of use was not known, preventing a comparison 
with other studies. There was a lower rate of cessation of implants as 
compared with IUDs, pills, or injections.30 Reduced bleeding caused 
by implants may be beneficial for sex workers, because bleeding can 
interfere with work. Heavier bleeding was associated with implant 
cessation, consistent with other research.30 Heavy bleeding caused 
by copper IUDs might negatively impact on sex work and exacer-
bate iron deficiency anemia, which is likely to be high in the present 
T A B L E  3   Characteristics of the study population by LARC use, and bivariate and multivariate logistic regression analyses of LARC use.a
Variable LARC use (95% CI)b
Unadjusted analysis Adjusted analysis
OR (95% CI) P value OR (95% CI) P value
Mean age, y 26.1 (25.3–26.8) 1.04 (1.00–1.08) <0.05 0.91 (0.86–0.96) <0.01
Education (highest level)
None or some primary 28.0 (21.0–36.2) Ref. Ref.
Primary or some secondary 29.5 (24.4–35.2) 1.08 (0.69–1.69) 0.95 (0.52–1.72)
Secondary or some tertiary 14.6 (10.8–19.6) 0.44 (0.27–0.73) <0.01 0.42 (0.22–0.83) <0.05
Weekly sex work income, shillings
<1000 23.2 (16.1–32.1) Ref. Ref.
1000–2000 27.1 (21.4–33.6) 1.23 (0.70–2.17) 1.26 (0.65–2.46)
>2000 23.2 (19.3–27.6) 1.00 (0.62–1.63) 1.06 (0.59–1.91)
Total lifetime pregnancies
0 2.75 (1.21–6.11) Ref. Ref
1 27.9 (22.4–34.2) 13.71 (5.54–33.89) <0.001 11.44 (4.25–30.83) <0.001
≥2 33.0 (28.1–38.3) 17.42 (7.32–41.42) <0.001 17.21 (6.32–46.81) <0.001
Knowledge, self- efficacy, and attitudes
High FP knowledge score 38.7 (33.1–44.7) 3.29 (2.40–4.51) <0.001 2.52 (1.78–3.56) <0.001
Median general self- efficacy score 3.6 (3.2–3.9) 1.02 (0.71–1.48) 1.11 (0.72–1.70)
High FP- specific self- efficacy 27.0 (23.2–31.2) 1.86 (1.19–2.88) <0.01 1.43 (0.86–2.36)
Positive attitude to FP use 34.7 (30.0–39.9) 5.65 (3.43–9.31) <0.001 4.58 (2.62–8.00) <0.001
Partner influence
Current boyfriend/husband 23.0 (19.1–27.5) 0.87 (0.62–1.22) 0.97 (0.64–1.46)
Intimate partner violence in last year 27.5 (23.7–31.8) 1.61 (1.16–2.23) <0.01 1.20 (0.82–1.75)
Social influence
Friends use FP (most or all) 28.9 (24.6–33.6) 1.92 (1.41–2.61) <0.001 1.25 (0.85–1.83)
Median stigma score 2.8 (2.4–3.0) 0.88 (0.63–1.23) 1.03 (0.71–1.49)
Health service experience
Sought health services in past 6 mo 24.2 (20.3–28.5) 1.01 (0.72–1.40) 0.83 (0.56–1.22)
Expect to be treated with respect by 
health worker
25.1 (21.6–28.9) 2.94 (1.04–8.25) <0.05 1.12 (0.30–4.13)
Abbreviations: CI, confidence interval; FP, family planning; OR, odds ratio.
aSample size, n=858 women (21 women had missing values for at least one variable). The proportion using LARC did not differ significantly between those 
with and without complete data. Values are given as mean (95% CI), median (IQR), or percentage (95% CI).
bInverse probability- weighted percentage. Standard errors are corrected by cluster sandwich variance estimation.
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population.14,31 Future studies should investigate whether hormonal 
IUDs, with their tendency to suppress bleeding, would have a higher 
uptake than copper IUDs.32 It would be particularly interesting to 
determine whether negative perceptions of the copper IUD are trans-
ferred to the hormonal one. Targeting additional resources at raising 
IUD uptake might help to overcome these barriers. It is possible, how-
ever, that such efforts might not raise uptake and that the method has 
low acceptability in this setting. If that is the case, then it may be better 
to target programmatic resources to other family planning priorities.
Pelvic pain was a frequently reported adverse effect and is also a 
symptom of cervicitis and pelvic inflammatory disease. The long- held 
misconception that IUDs cause pelvic inflammatory disease 21 may 
lead to their unnecessary removal, when in fact it is safe to leave them 
in situ while concurrent STIs are treated.4
Quality education and counseling on the benefits and adverse 
effects of LARCs can improve uptake and continuation rates 21,23 
by managing expectations, countering common myths, and provid-
ing reassurance on the safety of bleeding disturbances.32 However, 
counseling is likely to be insufficient or incomplete in many settings.30 
While Kenya has clear guidelines on contraceptive counseling,5 one 
study noted that only 60% of women were counseled on adverse 
effects when they obtained contraception.11 Further work is required 
to determine how guidelines are applied in practice, particularly for 
sex workers who are subject to discrimination by health workers.33 
Research in South Africa has indicated that, to improve uptake, LARCs 
need to be available from a wider range of trained service providers, 
including mobile outreach clinics for harder- to- reach populations such 
as FSWs, and counseling should be reoriented to emphasize LARCs as 
a “first- line” contraceptive method.34 Only 20% of private facilities in 
Kenya supply LARCs, whereas more than 65% supply other methods 
20 ― an observation reflected in the present data. Sex worker drop- in- 
centers supplied very few contraceptives (other than male condoms). 
This highlights a missed opportunity for these acceptable and widely 
used centers 33 to improve access to all methods including LARCs.
The study has some important limitations. The data were col-
lected by self- report, increasing the risk of recall bias and social 
desirability bias; however, it would not be possible or practicable 
to obtain such personal data by other means. Age was an inclusion 
criterion, so the results cannot be extrapolated to all ages. There 
are also limitations around the measurement of pregnancy inten-
tion, which may affect the reliability of these data. Some participants 
may not have intended to get pregnant, but nonetheless desired 
pregnancy for different reasons. FSWs often have mixed pregnancy 
intentions depending on their partners, so they must rely on short- 
acting methods with all partners except the desired father.35 They 
may also prefer not to disclose a true intention owing to the stigma 
surrounding sex work and motherhood.
Interpretation of the analysis is also limited by the cross- sectional 
design. Correlates such as knowledge may follow rather than pre-
cede LARC use. Other variables that might be associated with the 
outcome were not included; for example, stigma from health work-
ers may be an important structural determinant.33 Because there 
were very few current users of IUDs, the results of the regression 
were dominated by implant users. The low number of IUD users also 
precluded further examination of their adverse effects, patterns of 
use, and removal. The analysis of adverse effects had some limita-
tions: there were no data on duration of bleeding, which is a predic-
tor of cessation,30 and prolonged bleeding may have been instead 
reported as heavy or irregular.
In conclusion, despite the multiple sexual risks and difficul-
ties accessing services faced by FSWs in Kenya, implant use has 
increased and self- reported unintended pregnancy was lower as 
compared with previous estimates in this population. LARC use was 
strongly associated with gravidity, knowledge, and attitudes toward 
family planning. FSWs reported very high rates of contraceptive 
adverse effects. This population would benefit from interventions 
to improve uptake of LARCs, particularly IUDs, which are currently 
under- used.
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